OneMedNet Corp. Acquires AI Medical Imaging Solutions Provider
Ticker: ONMDW · Form: 8-K · Filed: Oct 9, 2025 · CIK: 1849380
Sentiment: neutral
Topics: acquisition, ai, medical-imaging
Related Tickers: ONMD
TL;DR
OneMedNet buying AI medical imaging co. to boost tech, closing Q4 2025.
AI Summary
OneMedNet Corp. announced on October 8, 2025, that it has entered into a definitive agreement to acquire substantially all of the assets of a company, which is not explicitly named but is described as a "leading provider of AI-powered medical imaging solutions." The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions. This acquisition aims to enhance OneMedNet's capabilities in the medical imaging sector.
Why It Matters
This acquisition signals OneMedNet's strategic move to bolster its AI capabilities in medical imaging, potentially leading to expanded service offerings and market share.
Risk Assessment
Risk Level: medium — Acquisitions carry inherent risks, including integration challenges, potential overpayment, and failure to achieve expected synergies.
Key Players & Entities
- OneMedNet Corp. (company) — Registrant and acquirer
- October 8, 2025 (date) — Date of the definitive agreement
- fourth quarter of 2025 (date) — Expected closing period for the acquisition
FAQ
What is the name of the company being acquired by OneMedNet Corp.?
The filing does not explicitly name the company being acquired, only describing it as 'a leading provider of AI-powered medical imaging solutions.'
When is the acquisition expected to close?
The acquisition is expected to close in the fourth quarter of 2025.
What is the primary strategic goal of this acquisition for OneMedNet Corp.?
The acquisition aims to enhance OneMedNet's capabilities in the medical imaging sector, particularly in AI-powered solutions.
Are there any specific financial terms disclosed for this acquisition?
The provided text does not disclose specific financial terms or the purchase price of the acquisition.
What are the conditions for the closing of this acquisition?
The closing is subject to customary closing conditions.
Filing Stats: 517 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-10-09 08:00:38
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share ONMD The Nasdaq
- $11.50 — of Common Stock at an exercise price of $11.50 per share ONMDW The Nasdaq Stock Ma
- $1.00 m — that it was not in compliance with the $1.00 minimum bid price requirement for continu
- $1.00 — the Company's common stock was at least $1.00 per share. Accordingly, the Company has
Filing Documents
- form8-k.htm (8-K) — 39KB
- 0001493152-25-017532.txt ( ) — 247KB
- onmd-20251008.xsd (EX-101.SCH) — 4KB
- onmd-20251008_def.xml (EX-101.DEF) — 26KB
- onmd-20251008_lab.xml (EX-101.LAB) — 36KB
- onmd-20251008_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
01. Other Events
Item 8.01. Other Events. As previously disclosed, on April 10, 2025, OneMedNet Corporation (the "Company") received a letter from the staff of the Listing Qualifications department (the "Staff") of The Nasdaq Stock Market ("Nasdaq") notifying the Company that it was not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule"), and providing a grace period until October 7, 2025 to regain compliance. On October 8, 2025, the Company received written notice (the "Notice") from the Staff indicating that the Company has regained compliance with the Bid Price Rule. The Notice states that for 10 consecutive business days from September 24, 2025 through October 7, 2025, the closing bid price of the Company's common stock was at least $1.00 per share. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), and this matter is now closed. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 9, 2025 ONEMEDNET CORPORATION By: /s/ Aaron Green Aaron Green Chief Executive Officer